|  |  | 

India Top Headlines

May manufacture and supply 10 crore doses of Covishield in June: Serum Institute to Center | India News


NEW DELHI: The Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to 10 crore doses of Covishield in June, official sources said Sunday amid complaints from states about coronavirus vaccine shortages . hits.
In a recent letter to the Union Interior Minister Amit Shah, the SII said that its employees have been working around the clock despite various challenges due to the pandemic.
“We are pleased to report that in June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to the country compared to our production capacity of 6.5 crore doses in May,” Prakash Kumar Singh. the SII Director of Government and Regulatory Affairs said in the letter.
Singh also thanked Shah for his “valuable guidance and continued support” at various stages of his effort to make India ‘aatmanirbhar’ (self-sufficient) on COVID-19 vaccines and make it available to the people of the country.
“Serum Institute of India has always been sincerely concerned about the protection of the citizens of our country and the world at large against COVID-19. Under the leadership of our CEO, Adar C Poonawalla, our team has been working tirelessly elbow side by side with our government to combat the COVID-19 pandemic, “he said in the letter.
“We assure you that with the support of the Government of India and under your kind guidance, we are doing our best to use all our resources to increase our Covishield production capacity also in the coming month.”
In early May, the SII had informed the Center that Covishield’s production would increase to 6.5 crore in June, seven crore in July and 10 crore each in August and September.
India currently uses vaccines made in India, Covishield made by SII and Covaxin from Bharat Biotech, in their Covid-19 immunization program.
Russia’s Sputnik V is the third vaccine to gain approval from the Comptroller General of Medicines of India (DCGI) for emergency use and is being used in some private hospitals.

Times of India